These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 3563448)
21. [A classification system for HTLV-III infected patients]. Solbach W Fortschr Med; 1986 Sep; 104(36):665-6. PubMed ID: 3639836 [No Abstract] [Full Text] [Related]
22. [Problems posed by the patient with positive serology for the HTLV-III/LAV retrovirus]. Zulaica D; Arrizabalaga J Med Clin (Barc); 1987 Jan; 88(3):117-22. PubMed ID: 3821274 [No Abstract] [Full Text] [Related]
23. Host immunity and the course of HIV infection. Bentwich Z; Wainberg MA Isr J Med Sci; 1993 Oct; 29(10 Suppl):34-6. PubMed ID: 8244678 [TBL] [Abstract][Full Text] [Related]
24. [Possibilities of vaccine prevention and virostatic therapy in HTLV-III/LAV infection]. Goebel FD Verh Dtsch Ges Inn Med; 1986; 92():341-3. PubMed ID: 3643689 [No Abstract] [Full Text] [Related]
25. Anergy and human immunodeficiency virus infection. Hegde HR; Robbins SM Med Hypotheses; 2001 Mar; 56(3):376-80. PubMed ID: 11359364 [TBL] [Abstract][Full Text] [Related]
26. [Immunologic restoration in patients with AIDS. Requiem for prophylaxis]. Peña JM; Miró JM Med Clin (Barc); 1999 Oct; 113(10):375-8. PubMed ID: 10562941 [No Abstract] [Full Text] [Related]
27. [Epidemiology and immunological study of LAV virus infection]. Gluckman JC; Brunet JB Rev Prat; 1986 Apr; 36(21):1157-62. PubMed ID: 3022368 [No Abstract] [Full Text] [Related]
28. AIDS vaccines: back to 'plan A'. Check E Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164 [No Abstract] [Full Text] [Related]
29. Structural and epidemiological features of primate lymphotropic retroviruses. Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632 [TBL] [Abstract][Full Text] [Related]
30. Antigen presentation and related immunological aspects of HIV-1 vaccines. Steinman RM; Germain RN AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991 [No Abstract] [Full Text] [Related]
31. Isolation of HTLV III/LAV from drug addicts in Palermo. Romano N; Portera M; Vitale F; Russo Alesi D; Torregrossa MV; Perrera G Microbiologica; 1987 Jan; 10(1):73-80. PubMed ID: 3646455 [TBL] [Abstract][Full Text] [Related]
32. [AIDS: risk due to the endogenous immune system. HIV is not primarily cytopathic]. Moosmann EB Fortschr Med; 1995 Apr; 113(11):30, 32. PubMed ID: 7768481 [No Abstract] [Full Text] [Related]
35. [Acquired immunodeficiency syndrome (a clinical case)]. Zimin IuI; Potekaev NS; Shuginina EA; Parfanovich MI Ter Arkh; 1987; 59(7):42-5. PubMed ID: 3672358 [No Abstract] [Full Text] [Related]
36. [Acquired immune deficiency syndrome: an infection complicated by more infections]. Latorre Capella X; Gatell Artigas JM Med Clin (Barc); 1986 Jan; 86(3):120-2. PubMed ID: 3959645 [No Abstract] [Full Text] [Related]
37. [Hiv and AIDS infection. A. History, definition and classification]. Cran S Acta Urol Belg; 1993; 61(1-2):353-61. PubMed ID: 8517255 [No Abstract] [Full Text] [Related]
38. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing. Ory HW; Koplan JP; Allen JR Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749 [TBL] [Abstract][Full Text] [Related]
40. Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients. Aidoo M; Nishiwaki O; Akari H; Brandful JA; Ampofo W; Hayami M; Ayisi NK West Afr J Med; 1994; 13(3):150-1. PubMed ID: 7841103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]